EBV and MSI Status in Gastric Cancer: Does It Matter?

EBV and MSI Status in Gastric Cancer: Does It Matter?

We investigated the impactof microsatellite instability (MSI) and Epstein–Barr virus (EBV) status in gastric cancer (GC), regarding response to perioperative chemotherapy (POPChT), overall survival (OS), and progression-free survival (PFS). We included 137 cases of operated GC, 51 of which were subm...

Full description

Bibliographic Details
Main Authors:	Catarina Neto do Nascimento, Luís Mascarenhas-Lemos, João Ricardo Silva, Diogo Sousa Marques, Catarina Ferreira Gouveia, Ana Faria, Sónia Velho, Rita Garrido, Rui Maio, Andreia Costa, Patrícia Pontes, Xiaogang Wen, Irene Gullo, Marília Cravo, Fátima Carneiro
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Cancers
Subjects:	gastric cancer Epstein–Barr virus microsatellite instability neoadjuvant chemotherapy perioperative chemotherapy predictor prognosis
Online Access:	https://www.mdpi.com/2072-6694/15/1/74

Similar Items

Epstein-Barr virus (EBV) induced pneumonitis in a patient with breast cancer receiving neoadjuvant chemotherapy: A case report
by: Huibin Liao, et al.
Published: (2023-01-01)

Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
by: Masanori Tokunaga, et al.
Published: (2023-11-01)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
by: Lisheng Zhu, et al.
Published: (2021-09-01)

Commentary on immune system associated diseases caused by viruses: the role of EBV
by: Joseph K Li, et al.
Published: (2011-02-01)

Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
by: Pengfei Su, et al.
Published: (2023-10-01)

Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma
by: Simona Secondino, et al.
Published: (2023-07-01)

The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer
by: Lei Cai, et al.
Published: (2020-07-01)

Editorial: Optimal perioperative management of urothelial carcinoma
by: Ariane Holzman, et al.
Published: (2023-05-01)

Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
by: Angelica Petrillo, et al.
Published: (2019-03-01)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
by: Hao Peng, et al.
Published: (2021-07-01)

EBV Infection Associated Neoplastic Lesions and Imaging Characteristics
by: Tong YU, et al.
Published: (2022-08-01)

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
by: Ferrari Daris, et al.
Published: (2012-05-01)

Predictive molecular markers of resistance to chemotherapy in breast cancer
by: Valerian Cucieru
Published: (2021-03-01)

Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response
by: Jiatong Lu, et al.
Published: (2023-05-01)

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
by: Thomas J. Ettrich, et al.
Published: (2018-12-01)

Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
by: Claudio Sergio Pannuti
Published: (1981-02-01)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01)

Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer
by: Na Yang, et al.
Published: (2021-05-01)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
by: Jun-Bing Chen, et al.
Published: (2022-12-01)

Risk stratification and beneficiary selection among elderly nasopharyngeal carcinoma patients from concurrent chemoradiotherapy combined with induction chemotherapy
by: Shuiqing He, et al.
Published: (2023-05-01)

Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
by: Qun Zhang, et al.
Published: (2023-01-01)

An Adult Case of Acute EBV Cerebellitis
by: Katya Muscat, et al.
Published: (2017-01-01)

Antiviral Drugs for EBV
by: Joseph S. Pagano, et al.
Published: (2018-06-01)

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Hua Zheng, et al.
Published: (2023-07-01)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
by: Sai-Lan Liu, et al.
Published: (2020-02-01)

Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
by: Anna‐Lina Herz, et al.
Published: (2022-05-01)

Signaling pathways of EBV-induced oncogenesis
by: Yin Luo, et al.
Published: (2021-02-01)

Acute pericarditis due to EBV infection: a case report
by: S. Alkan, et al.
Published: (2022-03-01)

Epstein–Barr virus (EBV) associated lymphoepithelioma-like cholangiocarcinoma with elevated EBV DNA titer and treated with systemic chemotherapy
by: Chen-Yang Huang, et al.
Published: (2017-03-01)

Gastric EBV‐positive mucocutaneous ulcer: A rare pathological entity
by: Azza Gabsi, et al.
Published: (2020-07-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

Risk model and factors for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer-a two-center cohort study
by: Xian-Wen Liang, et al.
Published: (2023-01-01)

EBV Seroepidemiology in Married and Unmarried Women and Men in Iran
by: Morteza Pourahamad, et al.
Published: (2014-05-01)

Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis
by: Shatadru Ghosh Roy, et al.
Published: (2016-11-01)

Diversity of adenosine deaminase in children with EBV-related diseases
by: Ting Shi, et al.
Published: (2022-08-01)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
by: Valli De Re, et al.
Published: (2022-11-01)

Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model
by: Xue-Song Sun, et al.
Published: (2020-02-01)

EBV and the Pathogenesis of NK/T Cell Lymphoma
by: Ivonne A. Montes-Mojarro, et al.
Published: (2021-03-01)